Business Wire18 日
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular ...
Evrysdi is the only non-invasive disease-modifying treatment for SMA. The 5 mg Evrysdi tablet can either be swallowed whole or dispersed in water. “Evrysdi has robust potential to modify the SMA ...